The effect of growth hormone on 24-h urinary creatinine levels in burned patients

Catabolism is increased in burned patients. Creatinine excreted in urine is accepted as an indicator of catabolism of muscle mass. Growth hormone (GH) is one of the most potent anabolic agents. We investigated the effect of GH on 24-h urinary creatinine levels as an indicator of catabolism of muscle...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Burns 2001-02, Vol.27 (1), p.42-45
Hauptverfasser: Akçay, Müfide Nuran, Akçay, Güngör, Solak, Sebahattin, Balık, A.Ahmet, Aylu, Belkız
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Catabolism is increased in burned patients. Creatinine excreted in urine is accepted as an indicator of catabolism of muscle mass. Growth hormone (GH) is one of the most potent anabolic agents. We investigated the effect of GH on 24-h urinary creatinine levels as an indicator of catabolism of muscle mass in burned patients. In 20 patients with severe burns, 24-h urinary creatinine levels were investigated for 3 days following hospitalisation. Then the patients were divided into two groups of 10. In the study group, following investigation of 24-h urinary creatinine levels for 3 days, GH 0.1 mg/kg was injected subcutaneously three times in a week. Following the last dose of GH, 24-h urinary creatinine levels were investigated for 3 days again. In the control group, an equal volume of isotonic saline solution was injected at the same times instead of GH, and 24-h urinary creatinine levels were investigated for 3 days again. Mean burn size and age were not significantly different between the groups. 24-h urinary creatinine level obtained in the early period was 48.5±16.6 mg/day in the study group and 49.9±11.3 mg/day in the control group. There was no statistical difference between these two values ( p>0.5). 24-h average urinary creatinine level obtained in the late period was 36.6±16.4 mg/day in the study group and 50.6±9.9 mg/day in the control group, and the difference was statistically significant ( p
ISSN:0305-4179
1879-1409
DOI:10.1016/S0305-4179(00)00056-5